Modulation of oxidant and antioxidant enzyme expression and function in vascular cells.
暂无分享,去创建一个
[1] Keiichiro Suzuki,et al. Induction of Thioredoxin Reductase Gene Expression by Peroxynitrite in Human Umbilical Vein Endothelial Cells , 2002, Biological chemistry.
[2] Rainer Hambrecht,et al. Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure: Results From 2 Placebo-Controlled Studies , 2002, Circulation.
[3] E. Schiffrin,et al. Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II , 2002, Circulation research.
[4] Don P Giddens,et al. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. , 2003, American journal of physiology. Heart and circulatory physiology.
[5] E. Schiffrin,et al. PPARα Activator Effects on Ang II–Induced Vascular Oxidative Stress and Inflammation , 2002 .
[6] E. Topol,et al. Prognostic value of myeloperoxidase in patients with chest pain. , 2003, The New England journal of medicine.
[7] T. Münzel,et al. Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus , 2001, Circulation research.
[8] S. Marklund,et al. Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. , 2000, Atherosclerosis.
[9] H. Utsumi,et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. , 2000, Diabetes.
[10] A. Wakatsuki,et al. Effect of Medroxyprogesterone Acetate on Endothelium-Dependent Vasodilation in Postmenopausal Women Receiving Estrogen , 2001, Circulation.
[11] S. Holland,et al. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. , 2001, The Journal of clinical investigation.
[12] S. Yusuf,et al. Vitamin E supplementation and cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.
[13] L. Oberley,et al. H2O2-induced O⨪2Production by a Non-phagocytic NAD(P)H Oxidase Causes Oxidant Injury* , 2001, The Journal of Biological Chemistry.
[14] J. Wilcox,et al. Upregulation of Nox‐Based NAD(P)H Oxidases in Restenosis After Carotid Injury , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[15] D. Harrison,et al. Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. , 1999, Circulation research.
[16] F. Cambien,et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. , 2003, The New England journal of medicine.
[17] L. Dobrucki,et al. Third-Generation &bgr;-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP Efflux: A Novel Mechanism for Antihypertensive Action , 2003, Circulation.
[18] J. Roman,et al. Peroxisome Proliferator-Activated Receptor &ggr; Ligands Increase Release of Nitric Oxide From Endothelial Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[19] R. Wiklund,et al. Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients , 2000 .
[20] T. Awata,et al. The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. , 2001, Metabolism: clinical and experimental.
[21] W. R. Taylor,et al. Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis , 2002, Circulation.
[22] U. Laufs,et al. Raloxifene Improves Endothelial Dysfunction in Hypertension by Reduced Oxidative Stress and Enhanced Nitric Oxide Production , 2002, Circulation.
[23] Steven M Holland,et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. , 2003, The Journal of clinical investigation.
[24] D. Harrison,et al. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. , 2000, Circulation research.
[25] C. Kim,et al. Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. , 2002, Diabetes.
[26] M. Hecker,et al. 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] U. Laufs,et al. Down-regulation of Rac-1 GTPase by Estrogen , 2003, The Journal of Biological Chemistry.
[28] KerstinStrehlow,et al. Modulation of Antioxidant Enzyme Expression and Function by Estrogen , 2003 .
[29] U. Walter,et al. Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling , 2002, Circulation research.
[30] K. Uchida,et al. 17beta-estradiol induces protein thiol/disulfide oxidoreductases and protects cultured bovine aortic endothelial cells from oxidative stress. , 1999, European journal of endocrinology.
[31] J. Díez,et al. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. , 2000, Hypertension.
[32] D. Harrison,et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. , 1999, Circulation.
[33] Georg Nickenig,et al. Angiotensin II Type 1 Receptor Antagonism Improves Hypercholesterolemia-Associated Endothelial Dysfunction , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[34] W. Klaus,et al. Nifedipine Increases Endothelial Nitric Oxide Bioavailability by Antioxidative Mechanisms , 2001, Hypertension.
[35] H. Drexler,et al. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. , 2000, Circulation.
[36] Friedrich C. Luft,et al. Endothelial Dysfunction and Xanthine Oxidoreductase Activity in Rats With Human Renin and Angiotensinogen Genes , 2001, Hypertension.
[37] S. Matsumoto,et al. Confirmation of Superoxide Generation via Xanthine Oxidase in Streptozotocin-induced Diabetic Mice , 2003, Free radical research.
[38] S. Marklund,et al. Vasoactive factors and growth factors alter vascular smooth muscle cell EC-SOD expression. , 2001, American journal of physiology. Heart and circulatory physiology.
[39] R. Busse,et al. Role of increased production of superoxide anions by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia. , 1999, Hypertension.
[40] G. Kojda,et al. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. , 2000, The Journal of clinical investigation.
[41] K. Uchida,et al. 17 b-Estradiol induces protein thiol / disulfide oxidoreductases and protects cultured bovine aortic endothelial cells from oxidative stress , 1999 .
[42] P. Seshiah,et al. Angiotensin II Stimulation of NAD(P)H Oxidase Activity: Upstream Mediators , 2002, Circulation research.
[43] E. Schiffrin,et al. PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. , 2002, Hypertension.
[44] S. Parthasarathy,et al. Lipid peroxides induce expression of catalase in cultured vascular cells. , 2000, Journal of lipid research.
[45] U. Laufs,et al. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. , 2001, Molecular pharmacology.
[46] T. Awata,et al. The ligands/activators for peroxisome proliferator-activated receptor α (PPARα) and PPARγ increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells , 2001 .
[47] Hua Cai,et al. Role of p47phox in Vascular Oxidative Stress and Hypertension Caused by Angiotensin II , 2002, Hypertension.
[48] T. Meinertz,et al. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. , 1999, Kidney international.
[49] D. Harrison,et al. Electron Spin Resonance Characterization of Vascular Xanthine and NAD(P)H Oxidase Activity in Patients With Coronary Artery Disease: Relation to Endothelium-Dependent Vasodilation , 2003, Circulation.
[50] M. Hecker,et al. 17β‐Estradiol inhibition of NADPH oxidase expression in human endothelial cells , 2001 .
[51] K. Channon,et al. Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase , 2002, Circulation.
[52] J. Beltrame,et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial☆ , 2002 .
[53] J. Sastre,et al. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. , 2002, Diabetes.
[54] U. Laufs,et al. Cellular Antioxidant Effects of Atorvastatin In Vitro and In Vivo , 2002, Arteriosclerosis, thrombosis, and vascular biology.